Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (Her3-Dxd) in EGFR-mutated NSCLC.

H. A. Yu,C. Baik,D. -W. Kim,M. L. Johnson, H. Hayashi, M. Nishio,J. C. -H. Yang,W. -C. Su,K. A. Gold,M. Koczywas,E. F. Smit,C. E. Steuer,E. Felip, H. Murakami,S. -W. Kim, X. Su, S. Sato,P. -D. Fan, M. Fujimura, Y. Tanaka, P. Patel,D. W. Sternberg,D. Sellami,P. A. Jaenne

ANNALS OF ONCOLOGY（2024）

Cited 0|Views41
No score
Key words
lung cancer,antibody- drug conjugate
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined